(October 16, 2012) -- The Justice Department is seeking Supreme Court review of a recent federal appeals court ruling that upheld the dismissal of a case involving a challenge to a scheme that postponed a generic drug’s entry into the market. The Federal Trade Commission had brought a case that challenged a “pay-for-delay” agreement by which a generic alternative to the testosterone-replacement drug AndroGel was delayed from coming to the market....